MedPath

effect of devdaruvadi churna,shunthyadi kwatha and saindhwadi tail matra basti in AMAVATA (RHEUMATOID ARTHRITIS)

Phase 1
Conditions
Health Condition 1: M048- Other autoinflammatory syndromes
Registration Number
CTRI/2019/02/017640
Lead Sponsor
Rishikul Campus
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients fulfilling American College of Rheumatology (ACR) criteria,1987.

Exclusion Criteria

Patients having severe crippling deformity.

Patients with other systemic diseases like cardiac diseases ,TB,DM ect. Any other serious medically and surgically ill patients

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To assess the effect of therapy,objectively all sign and symptoms were given scoring depending upon their severity. <br/ ><br>complete remission-100% <br/ ><br>maximum improvement-75-99% <br/ ><br>moderate improvement-50-74% <br/ ><br>mild improvement-25-49% <br/ ><br>no improvement-0-24% <br/ ><br>Timepoint: Duration of study -45 days <br/ ><br>The assessment of the patients will be done for three times at the interval of 15 days <br/ ><br>Follow up of the patients will be done 30 days after completion of trial. <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
Relief in all sign and symptomes of AmavataTimepoint: 45 days
Âİ Copyright 2025. All Rights Reserved by MedPath